The diversity in the vanilloid (TRPV) receptor family of ion channels

Trends in Pharmacological Sciences
Martin J GunthorpeJohn B Davis

Abstract

Following cloning of the vanilloid receptor 1 (VR1) at least four other related proteins have been identified. Together, these form a distinct subgroup of the transient receptor potential (TRP) family of ion channels. Members of the vanilloid receptor family (TRPV) are activated by a diverse range of stimuli, including heat, protons, lipids, phorbols, phosphorylation, changes in extracellular osmolarity and/or pressure, and depletion of intracellular Ca2+ stores. However, VR1 remains the only channel activated by vanilloids such as capsaicin. These channels are excellent molecular candidates to fulfil a range of sensory and/or cellular roles that are well characterized physiologically. Furthermore, as novel pharmacological targets, the vanilloid receptors have potential for the development of many future disease treatments.

References

Oct 1, 1992·British Journal of Pharmacology·S BevanJ C Yeats
Jun 1, 1996·Neuron·D E Clapham
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·P Cesare, P McNaughton
Nov 14, 1997·Physiological Reviews·A B Parekh, R Penner
May 15, 1998·Neuron·W D Snider, S B McMahon
Aug 4, 1998·Current Opinion in Neurobiology·P C GrayW A Catterall
Feb 26, 1999·The Journal of Biological Chemistry·M SuzukiM Imai
Mar 20, 1999·The Journal of Biological Chemistry·J G HoenderopR J Bindels
Jul 22, 1999·Annals of the New York Academy of Sciences·P J WhitingK A Wafford
Oct 6, 1999·Current Opinion in Neurobiology·M J Caterina, D Julius
Nov 5, 1999·Trends in Pharmacological Sciences·O Sterner, A Szallasi
Nov 24, 1999·Neuroscience Letters·A HoriS Kobayashi
Dec 10, 1999·Molecular and Cellular Neurosciences·A Randall, C D Benham
Feb 8, 2000·The Journal of Biological Chemistry·R VennekensR J Bindels
Feb 29, 2000·British Journal of Pharmacology·D SmartJ B Davis
Mar 16, 2000·Trends in Neurosciences·C HarteneckG Schultz
Mar 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·E MezeyA Szallasi
Apr 14, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·J N Wood
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·S W HwangU Oh
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·S E JordtD Julius
Jul 6, 2000·The Journal of Biological Chemistry·J B PengM A Hediger
Jul 15, 2000·Neuron·D B Reichling, J D Levine
Sep 28, 2000·Trends in Neurosciences·A Szallasi, V Di Marzo
Nov 30, 2000·FEBS Letters·U WissenbachV Flockerzi
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·J M WelchP H Reinhart
Dec 1, 2000·Biochemical and Biophysical Research Communications·J B PengM A Hediger
Dec 1, 2000·Progress in Brain Research·P W Reeh, G Pethö

❮ Previous
Next ❯

Citations

May 27, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Martin GoslingSu Li
Jul 26, 2005·Histochemistry and Cell Biology·Maria-Simonetta Faussone-PellegriniPaolo Bechi
Mar 31, 2006·Langenbeck's Archives of Surgery·Mario H MuellerMartin E Kreis
Oct 14, 2004·Pflügers Archiv : European journal of physiology·Joris VriensBernd Nilius
Mar 8, 2006·Pflügers Archiv : European journal of physiology·Joseph Santos-SacchiDhasakumar Navaratnam
Sep 1, 2005·Pflügers Archiv : European journal of physiology·James W Putney
Jul 27, 2005·Pflügers Archiv : European journal of physiology·Tom NijenhuisRené J M Bindels
Jul 14, 2005·Pflügers Archiv : European journal of physiology·Bernd Nilius, Thomas Voets
Oct 7, 2009·Pflügers Archiv : European journal of physiology·Michael Henrich, Keith J Buckler
Sep 10, 2011·Pflügers Archiv : European journal of physiology·Valentina ComunanzaDaniel Ursu
Jan 28, 2005·Cellular and Molecular Neurobiology·Changjong MoonTaekyun Shin
Sep 1, 2005·Cellular and Molecular Neurobiology·Srihasam Lakshmi, Preeti G Joshi
Jan 5, 2012·The Journal of Physiological Sciences : JPS·Kyung Soo KimSung Joon Kim
Sep 14, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gholam K MotamediStefano Vicini
Dec 4, 2003·Current Opinion in Pharmacology·Peter Holzer
Mar 1, 2005·European Journal of Pharmacology·Riccardo PatacchiniCarlo Alberto Maggi
Nov 5, 2003·Gastroenterology·Kenneth LambKlaus Bielefeldt
Jun 7, 2005·Life Sciences·Luciano De Petrocellis, Vincenzo Di Marzo
May 17, 2005·Brain Research. Molecular Brain Research·Shinya UgawaShoichi Shimada
Oct 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Boris A Chizh, Christine N Sang
Mar 12, 2004·Urology·Michael B Chancellor, Naoki Yoshimura
Sep 10, 2003·Biochemical Pharmacology·Shinichi KatoKoji Takeuchi
Sep 5, 2003·European Journal of Pharmacology·Selena HarrisonVincenzo Di Marzo
Sep 5, 2003·Physiology & Behavior·Barry G Green, John E Hayes
Jun 5, 2003·Toxicon : Official Journal of the International Society on Toxinology·Paula R S CâmaraEdson Antunes
Jul 6, 2002·Cell Calcium·R VennekensB Nilius
May 27, 2003·Cell Calcium·Christopher D BenhamJohn B Davis
May 27, 2003·Cell Calcium·Els den DekkerRené J M Bindels
Jun 5, 2003·Neurotoxicology·Bellina VeronesiMarga Oortgiesen
Apr 5, 2003·Molecular and Cellular Neurosciences·Shaista HayatJon Robbins
Mar 12, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Masahiro KondohHideyoshi Yokosawa
Feb 19, 2005·Drug Discovery Today·Su LiBrian Cox
Dec 17, 2002·Current Opinion in Pharmacology·Paul L R Andrews, Gareth J Sanger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.